Dr. Atul Ambekar
National Drug Dependence Treatment Centre
AIIMS, New Delhi, India
Dr. Atul Ambekar is an addiction psychiatrist, working as a professor at the prestigious National Drug Dependence treatment Centre (NDDTC), AIIMS, New Delhi. He divides his time between clinical-care, teaching, training, research and public health program activities. He is a passionate advocate of evidence-informed alcohol and drug policies and programmes.
He has authored a number of publications including research papers, practice guidelines, and training manuals. He has been providing his expertise to many national and international agencies including UNODC, WHO and INCB. Epidemiology is another area close to his heart, and he has recently concluded the largest national survey on alcohol and drugs in India.
Dr. Wei Hao
Mental Health Institute, Central South University
Dr. Wei Hao is a Professor of Psychiatry and the Deputy Director of the Mental Health Institute, Central South University, Changsha, China. He is also the Director of the World Health Organization (WHO) Collaborating Centre for Psychosocial Factors, Substance Abuse and Health.
Dr. Hao is a Member of WHO Expert Advisory Panel on Drug Dependence and Alcohol Problems (2006-present); and a Member of the Working Group on the Classification of Substance Abuse for the eleventh revision of the International Classification of Diseases (ICD-11), WHO (2011-present). Further on, he is the President of Chinese Association of Drug Abuse Prevention and Treatment (2015-present) and First-Vice President of International Narcotics Control Board (2017).
Dr Amy O’Donnell
Population Health Sciences Institute
Newcastle University, UK
Dr Amy O’Donnell is a Senior Research Fellow at the Population Health Sciences Institute, Newcastle University, UK. Her work focusses on advancing the implementation of evidence-based substance use interventions in global healthcare systems.
A keen advocate for innovative, interdisciplinary approaches, Dr O’Donnell has specific expertise in mixed-methods research, evidence synthesis techniques, and implementation science.
A member of the INEBRIA Coordinating Committee and Associate Editor for Alcohol and Alcoholism, her current portfolio includes the Horizon 2020 SCALA study, which seeks to improve care for patients with co-morbid heavy drinking and depression in Latin America, and the European ATTUNE project, which explores factors shaping amphetamine-use pathways over the life course.
Previously, Dr O’Donnell worked on the Cochrane Review of Digital Interventions for Heavy Drinking, the EU BISTAIRS project, and held a Visiting Fellowship in Implementation Science at Linkoping University, Sweden.
Dr Pratima Murthy
Department of Psychiatry
NIMHANS, Bangalore, India
Professor Pratima Murthy heads the Department of Psychiatry at NIMHANS, Bangalore, where she earlier headed the Centre for Addiction Medicine.
A clinician, trainer and researcher primarily in addiction and mental health, she has edited several manuals on addiction treatment and management and has been an international trainer for the WHO, UNODC and ILO in tobacco, alcohol and other drug cessation. She is involved in mCessation initiatives for tobacco, virtual training through the ECHO, as well as post graduate training and research in these areas.
She also works in forensic psychiatry, human rights of the mental ill and documentation of the history of psychiatry.
Professor Kypros Kypri is a behavioural scientist interested in the evaluation of policies and interventions to reduce alcohol-related harm. He was trained in psychology and public health at the University of New South Wales, the University of California San Diego, and the University of Otago, New Zealand. He is a Professor at the School of Medicine & Public Health, University of Newcastle, Australia.